Note: This post was crossposted from the Coefficient Giving Farm Animal Welfare Research Newsletter by the Forum team, with the author's permission. The author may not see or respond to comments on this post.
Subtitle: On vegan advocacy, effective altruism, and FIFA
I turn 40 today. Here are some hot takes.
On factory farming
1. Our biggest challenge is salience. If factory farming led the evening news, it wouldn’t last lo...
Previously: GiveWell raised less than its 10th percentile forecast in 2023 · GiveWell fundraising up 17% in 2024
GiveWell has published its...
Summary
Over the course of a year, the Fieldshaper program develops you into a field-leading grantmaker. You’ll steward $1,000,000 in grant capital, receive a $125,000 annual stipend, and deploy that capital within a sub-field of one of three key areas (farmed animals, global health, or philanthropic infrastructure); building the track record to become a grantmaker who can shape a field.
Role Details
* Title: Grantmak...
New anti-malaria treatment clears phase 3 trials.
I just found that there is a new anti-malarial alternative to artemisinin, the most common antimalarial chemical, which has successfully completed Phase 3 trials. Its nickname is GanLum and apparently has quite powerful effects:
This is an important advance because resistance to artemisinin is one of the growing concerns in the fight against malaria.
You may read more in https://www.npr.org/sections/goats-and-soda/2025/11/12/g-s1-97487/malaria-drug-new and https://www.mmv.org/newsroom/news-resources-search/phase-3-trial-next-generation-malaria-treatment-ganaplacide-lumefantrine .
Very interesting! And very hopeful! Thanks for sharing!